BioForce Nanosciences Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$471,953 over the previous period. Total operating expenses were $471,953.

Profit Margin

BioForce Nanosciences Holdings, Inc. (OTC:BFNH): Profit margin
2014 0 -2.5K
2015 6.07K -2.5K -41.15%
2016 8.25K -2.5K -30.3%
2017 4.5K -31.26K -694.69%
2018 16.31K -67.73K -415.32%
2019 17.77K -46.53K -261.82%
2020 0 -158.40M
2021 0 -501.95K
2022 0 -485.51K
2023 0 -471.95K

BFNH Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000017.77K16.31K4.5K8.25K6.07K0
Cost of revenue
000013.41K11.64K3.24K6K5.28K0
Gross profit
00004.36K4.66K1.25K2.25K7950
Operating exp.
Research and development
0000000000
Selling and marketing
0000000000
Total operating expenses
471.95K485.51K501.95K158.40M50.89K71.40K32.51K2.5K2.5K2.5K
Operating income
-471.95K-485.51K-501.95K-158.40M-46.53K-66.74K-31.26K-2.5K-2.5K-2.5K
Other income (expenses), net
0-4402-9980000
Income before tax
-471.95K-485.51K-501.95K-158.40M-46.53K-67.73K-31.26K-2.5K-2.5K-2.5K
Income tax expense
0-489-496-158.40K-441.99K-31.26K0-5.50K0
Net income
-471.95K-485.51K-501.95K-158.40M-46.53K-67.73K-31.26K-2.5K-2.5K-2.5K
Earnings per share
Basic EPS
-0.02-0.01-0.01-9.72-0.00-0.00-0.00-0.00-0.00-0.00
Diluted EPS
-0.01-0.01-0.01-9.72-0.00-0.00-0.00-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData source